Ion Channels: Signaling the differences between cilia
Almost all eukaryotic cells have hair-like projections called cilia on their surface. Cilia sense environmental cues, play crucial roles in organ development, and are responsible for moving cells and fluids. Problems that affect how cilia work cause a diverse set of ‘ciliopathies’, including polycystic kidney disease, infertility, airway diseases and hearing defects (Fliegauf et al., 2007). But how do cilia differ among various cell types?
Calcium ion (Ca2+) signaling is central for controlling how cilia move and respond to signals received from outside the cell (Phua et al., 2015). Now, in eLife, Julia Doerner, Markus Delling and David Clapham at Harvard Medical School and Boston Children’s Hospital demonstrate that the key principles of Ca2+ signaling differ significantly between different types of cilia (Doerner et al., 2015).
Cilia are categorized as either primary cilia or undulipodia based on obvious structural differences (Figure 1). Primary cilia are not able to move themselves, but help cells detect external cues and serve as a signaling hub during development (Goetz and Anderson, 2010). In contrast, undulipodia are able to move themselves and are subdivided into motile cilia that move fluid over the outer surface of the cell, and flagella that propel the cell through fluids (Fliegauf et al., 2007). Ciliary movement is directly associated with the axoneme – a structure made of microtubules that serves as a ‘skeleton’ and extends along the length of the cilium. All primary cilia contain nine pairs of microtubules that are arranged in a circle to give the so called 9+0 structure. Undulipodia have two additional microtubules in the center of the axoneme (the 9+2 arrangement; Figure 1).
Beyond these obvious differences in structure, differences in the molecular pathways that control how the cilia work remained largely unknown. Direct investigation of the molecular composition of cilia is challenging, mainly due to their small size, the extremely low volume of ciliary cytosol, and the tight structural associations between various molecular components. Together, these adverse factors complicate the application of all biochemical, electrophysiological, or optical analytic methods.
However, since 2001 the Clapham lab has been instrumental in using the patch-clamp technique to study various ciliary structures, starting with the discovery of a mysterious channel-like protein located in the sperm flagellum (Ren et al., 2001). This protein, called CatSper, is structurally similar to the voltage-gated Ca2+ channels found in neurons. However, in the CatSper channel four individual subunits work together to form a functional channel, whereas in neuronal channels the four subunits are linked into a single molecule. Applying the whole-cell patch-clamp technique to sperm cells revealed that CatSper is only weakly voltage-dependent, defying expectations. Instead, its activity is controlled by the pH inside the cell (Kirichok et al., 2006) and by the female steroid hormone progesterone (Lishko et al., 2011; Strunker et al., 2011). CatSper is now established as the principal, and perhaps only, Ca2+ channel in the flagella of sperm cells and is, therefore, indispensable for normal sperm motility and male fertility (Figure 1).
In another technological and conceptual breakthrough in 2013, the Clapham group applied the patch-clamp technique directly to primary cilia and found that the main Ca2+ channel of this organelle consists of two subunits: PKD1L1 and PKD2L1 (DeCaen et al., 2013; Delling et al., 2013; Figure 1). These proteins belong to a group of proteins called polycystins, some of which are mutated in patients with polycystic kidney disease. In mice, PKD1L1 mutations disrupt left-right patterning and cause the developing embryos to die (Field et al, 2011). In contrast, PKD2L1-deficient mice can survive, but demonstrate intestinal malrotation – a condition that causes parts of the gut to develop in the wrong positions (Delling et al., 2013). The Clapham group demonstrated that PKD1L1-PKD2L1 channels in the ciliary membrane cause a resting Ca2+ concentration that is approximately five times greater in the primary cilia than in the cell body. Thus, primary cilia are a specialized Ca2+ signaling organelle, in which Ca2+ may be required for regulating sonic hedgehog and other signaling pathways.
Doerner, Delling and Clapham have now made the first patch-clamp recordings on motile cilia. The recordings were made on ependymal cells, which line fluid-filled spaces in the brain and spinal cord, and revealed several differences between motile cilia and other cilia types. Firstly, the abundance of Ca2+ channels in the plasma membrane of motile cilia appears to be much lower than in primary cilia and flagella. Only one type of Ca2+ channel was apparently present in the motile cilia of ependymal cells: a voltage-gated Ca2+ channel (in the Cav1 subfamily). Moreover, the ciliary membrane contained many fewer of these channels than the plasma membrane of the rest of the cell (Figure 1).
Furthermore, Doerner et al. found that the resting Ca2+ concentration in the motile cilia was much lower than that in primary cilia. Finally, although the voltage-gated Ca2+ channels cause a substantial elevation of the Ca2+ concentration inside the cilium upon membrane depolarization, this does not measurably change ciliary motility. This is in striking contrast to the sperm flagellum, where motility is strongly regulated by the movement of Ca2+ ions through CatSper. However, a possibility still remains that in addition to voltage-gated Ca2+ channels, motile cilia contain other, yet unidentified, types of Ca2+ channels that would be more efficient in controlling ciliary beat.
The remarkable technical and conceptual advances made by the Clapham group should lead to the discovery of other ion channels and new regulatory pathways in these fascinating structures.
References
-
When cilia go bad: cilia defects and ciliopathiesNature Reviews Molecular Cell Biology 8:880–893.https://doi.org/10.1038/nrm2278
-
The primary cilium: a signalling centre during vertebrate developmentNature Reviews Genetics 11:331–344.https://doi.org/10.1038/nrg2774
Article and author information
Author details
Publication history
Copyright
© 2015, Lishko et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,225
- views
-
- 361
- downloads
-
- 5
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Lipopolysaccharides (LPS) confer resistance against harsh conditions, including antibiotics, in Gram-negative bacteria. The lipopolysaccharide transport (Lpt) complex, consisting of seven proteins (A-G), exports LPS across the cellular envelope. LptB2FG forms an ATP-binding cassette transporter that transfers LPS to LptC. How LptB2FG couples ATP binding and hydrolysis with LPS transport to LptC remains unclear. We observed the conformational heterogeneity of LptB2FG and LptB2FGC in micelles and/or proteoliposomes using pulsed dipolar electron spin resonance spectroscopy. Additionally, we monitored LPS binding and release using laser-induced liquid bead ion desorption mass spectrometry. The β-jellyroll domain of LptF stably interacts with the LptG and LptC β-jellyrolls in both the apo and vanadate-trapped states. ATP binding at the cytoplasmic side is allosterically coupled to the selective opening of the periplasmic LptF β-jellyroll domain. In LptB2FG, ATP binding closes the nucleotide binding domains, causing a collapse of the first lateral gate as observed in structures. However, the second lateral gate, which forms the putative entry site for LPS, exhibits a heterogeneous conformation. LptC binding limits the flexibility of this gate to two conformations, likely representing the helix of LptC as either released from or inserted into the transmembrane domains. Our results reveal the regulation of the LPS entry gate through the dynamic behavior of the LptC transmembrane helix, while its β-jellyroll domain is anchored in the periplasm. This, combined with long-range ATP-dependent allosteric gating of the LptF β-jellyroll domain, may ensure efficient and unidirectional transport of LPS across the periplasm.
-
- Structural Biology and Molecular Biophysics
Polycystin-1 (PC1) is the protein product of the PKD1 gene whose mutation causes autosomal dominant Polycystic Kidney Disease (ADPKD). PC1 is an atypical G protein-coupled receptor (GPCR) with an autocatalytic GAIN domain that cleaves PC1 into extracellular N-terminal and membrane-embedded C-terminal (CTF) fragments. Recently, activation of PC1 CTF signaling was shown to be regulated by a stalk tethered agonist (TA), resembling the mechanism observed for adhesion GPCRs. Here, synthetic peptides of the first 9- (p9), 17- (p17), and 21-residues (p21) of the PC1 stalk TA were shown to re-activate signaling by a stalkless CTF mutant in human cell culture assays. Novel Peptide Gaussian accelerated molecular dynamics (Pep-GaMD) simulations elucidated binding conformations of p9, p17, and p21 and revealed multiple specific binding regions to the stalkless CTF. Peptide agonists binding to the TOP domain of PC1 induced close TOP-putative pore loop interactions, a characteristic feature of stalk TA-mediated PC1 CTF activation. Additional sequence coevolution analyses showed the peptide binding regions were consistent with covarying residue pairs identified between the TOP domain and the stalk TA. These insights into the structural dynamic mechanism of PC1 activation by TA peptide agonists provide an in-depth understanding that will facilitate the development of therapeutics targeting PC1 for ADPKD treatment.